Cardiovascular Therapy and Prevention, 2006; 5(6)

Contents

Leading article

COULD HEART RATE BE REGARDED AS CARDIOVASCULAR DISEASE RISK FACTOR?

V.I. Makolkin, F.N. Zyabrev
I.M. Sechenov Moscow Medical Academy. Moscow, Russia

Abstract

Originalarticles

Arterialhypertension

HIGH SYSTOLIC BLOOD PRESSURE: FOCUS ON ARTERIAL ELASTICITY

Zh.D. Kobalava, Yu.V. Kotovskaya, M.A. Markova, S.V. Villevalde
Russian University
of People’s Friendship, City Clinical Hospital No. 64

Abstract

ARTERIAL HYPERTENSION FEATURES IN THE ELDERLY AND ITS CORRECTION

L.I. Katelnitskaya, L.A. Khaisheva, S.A. Pleskachev
State Medical University, Clinical Hospital No.1, South Medical Center. Rostov-na-Donu, Russia

Abstract

PROLOG STUDY: MAIN RESULTS AND GUIDANCE FOR FURTHER ACTION

S.Yu. Martsevich, S.A. Shalnova, A.D. Deev, N.P. Kutishenko, V.V. Yakusevich,
on behalf of the Working Group «PROLOG sudy» Society of Cardiology of the Russian Federation.

Abstract

MICROCIRCULATION IN ARTERIAL HYPERTENSION PATIENTS RECEIVING BETA-ADRENOBLOCKERS

LL. Kirichenko, O.V. Vostryakova, Yu.A. Babich, N.V. Burlyay, Zh.I. Vasheva, A.P. Korolev, O.B. Golovkova
Moscow State Medico-Stomatological University.
Moscow, Russia.

Abstract

ЕPROSARTAN THERAPY EFFECTIVENESS IN ARTERIAL HYPERTENSION PATIENTS AFTER STROKE OR TRANSIENT ISCHEMIC ATTACK

Yu.M. Pozdnyakov, A.M. Urinsky, R.L. Kuznetsov, S.V. Belonosova, I.B. Ryzhikova, I.D. Bondarenko, O.V. Patrikhalkina
Moscow Regional Cardiology Center. Zhukovsky, Russia.

Abstract

Ishemic heart desease

RANDOMIZED «FARVATER» STUDY. ATORVASTATIN (10 AND 20 MG/D) IN TREATING PATIENTS WITH CORONARY HEART DISEASE AND DYSLIPIDEMIA: EFFECTS ON LIPIDS, C-REACTIVE PROTEIN AND FIBRINOGEN LEVELS.

A.V. Susekov, M.Yu. Zubareva, M.I. Tripoten’, T.A. Rozhkova, O.A. Pogorelova, T.V. Balakhonova, V.P. Masenko, V.V. Kukharchuk.
Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development.Moscow, Russia

Abstract

HYPOLIPIDEMIC EFFECTIVENESS AND SAFETY OF GENERIC LOVASTATIN

D.M. Aronov1, V.V. Kukharchuk2, V.G. Kukes3, M.G. Bubnova1,
on behalf of the Working Group*
1State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development, 2A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development,
3I.M. Sechenov Moscow Medical Academy, State Federal Agency for Health and Social Development. Moscow, Russia

Abstract

PREMIERE STUDY: REACHING TARGET BLOOD PRESSURE LEVEL – A SUCCESS IN CORONARY HEART DISEASE TREATMENT

Yu. A. Karpov1, S.A. Shalnova2, A.D. Deev2, on behalf of the Working Group*
1Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development, 2State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development. Moscow, Russia.

Abstract

THE EFFECTS OF VARIOUS STREPTOKINASE THROMBOLYSIS REGIMENS ON COAGULATION HEMOSTASIS AND FIBRINOLYSIS IN ACUTE MYOCARDIAL INFARCTION

Ya.L. Gabinsky, S.G. Kalinina
Clinical Center «Cardiology». Yekaterinburg, Russia

Abstract


Opinion upon problem

ASPIRIN FOR THROMBOEMBOLIC COMPLICATION PREVENTION IN CARDIOVASCULAR DISEASE: DOSE OPTIMIZATION AND ADVERSE EFFECT MINIMIZATION

A.N. Britov
State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development. Moscow, Russia

Abstract

?3-POLYUNSARTURATED FATTY ACID MEDICATIONS IN CARDIOVASCULAR EVENT PREVENTION

K.A. Talitsky, Yu.A. Karpov
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development. Moscow, Russia.

Abstract

CARDIOVASCULAR RISK FACTORS AND THEIR CONTROL IN EARLY XXI CENTURY (REACH REGISTRY DATA)

E.P. Panchenko
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex. Moscow, Russia.

Cardiovascular Therapy and Prevention, 2006; 5(6): 91-94

STATINOTHERAPY – THE PARADIGM OF PREVENTION AND TREATMENT OF ATHEROSCLEROTIC PATHOLOGY (FOCUS ON ATORVASTATIN)

R.G. Oganov, D.M. Aronov, M.G. Bubnova
State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development. Moscow, Russia

Abstract

Review articles

PLANT STANOL ETHERS: PERSPECTIVES AND EFFECTS IN NON-PHARMACEUTICAL PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR PATHOLOGY

N.V. Perova
State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development. Moscow, Russia.

Abstract

PRINZMETAL ANGINA: NEW APPROACHES TO PATHOGENESIS AND TREATMENT.

I.G. Fomina, V.V. Matveev, N.A. Galanina, E.L. Perskaya
I.M. Sechenov. Moscow Medical Academy. Moscow, Russia

Abstract

ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE: OLD PROBLEM, NEW APPROACHES

S.I. Gamidov, V.V. Iremashvili
Russian State Medical University, State FederalAgency for Health and Social Development. Moscow, Russia.

Abstract

ENDOTHELIAL DYSFUNCTION ROLE IN ATHEROSCLEROSIS PATHOGENESIS

E.N. Vorobyeva, G.I. Shumakher, I.V. Osipova, M.A. Khoreva, R.I. Vorobyev
Altay State Medical University. Barnaul, Russia

Abstract

Current Events

First Educational Seminar on Cardiology, ChechenRepublic

Cardiovascular Therapy and Prevention, 2006; 5(6): 137

Information

II Meeting of Ural Federal Region Cardiologists

Яндекс.Метрика